ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer

T Thomas Powles (Department of Medical Oncology Barts Cancer Institute Queen Mary University of London London UK) A Ariel G. Kann (Hospital Alemão Oswaldo Cruz, São Paulo) D Daniel Castellano (Hospital Universitario 12 de Octubre, Madrid) M Marine Gross-Goupil (University Hospital of Bordeaux, Bordeaux, France) H Hiroyuki Nishiyama (University of Tsukuba, Tsukuba, Japan) S Sergio Bracarda (Azienda Ospedaliera Santa Maria, Terni, Italy) J Jørgen Bjerggaard Jensen (Aarhus University, Aarhus, Denmark) L Lydia Makaroff (Fight Bladder Cancer, Chinnor, United Kingdom) S Shusuan Jiang (Hunan Cancer Hospital, Changsha, China) J Ja Hyeon Ku (Seoul National University Hospital, Seoul, South Korea) S Se Hoon Park O Oscar Reig Torras (Department of Medical Oncology, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Hospital Clinic, Barcelona) D Dingwei Ye (Fudan University Shanghai Cancer Center, Shanghai) M Marco Maruzzo (Istituto Oncologico Veneto (IOV)–IRCCS, Padua, Italy) A Andrea Necchi (Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Milan Italy) R Rafael Morales-Barrera (Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona) E Emilio Francesco Giunta (Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori,” IRCCS, Meldola, Italy) J Jae Lyun Lee G Giampaolo Tortora Y Yüksel Ürün (Ankara University Medical Faculty, Ankara, Turkey) L Lukasz Dolowy (University Clinical Hospital, Warsaw, Poland) D Dilek Erdem (Istinye University Medical Faculty, Istanbul, Turkey) A Alvaro Pinto (University Hospital La Paz, Madrid) F Fabricio Grando (Centro de Pesquisas Oncológicas, Florianópolis, Brazil) W Wei Zou Z Zoe June Assaf (Genentech, South San Francisco, CA) J Jacqueline Vuky (Genentech, South San Francisco, CA) V Viraj Degaonkar (Azienda Ospedaliera Santa Maria, Terni, Italy) E Elizabeth E. Steinberg (Genentech, South San Francisco, CA) J Joaquim Bellmunt (Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA) J Jürgen E. Gschwend (Technical University Munich, Munich, Germany)

Article Details

Volume / Issue Vol. 393, Issue 24
Published December 18, 2025
Pages 2395-2408
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (31)

T

Thomas Powles

Department of Medical Oncology Barts Cancer Institute Queen Mary University of London London UK

A

Ariel G. Kann

Hospital Alemão Oswaldo Cruz, São Paulo

D

Daniel Castellano

Hospital Universitario 12 de Octubre, Madrid

M

Marine Gross-Goupil

University Hospital of Bordeaux, Bordeaux, France

H

Hiroyuki Nishiyama

University of Tsukuba, Tsukuba, Japan

S

Sergio Bracarda

Azienda Ospedaliera Santa Maria, Terni, Italy

J

Jørgen Bjerggaard Jensen

Aarhus University, Aarhus, Denmark

L

Lydia Makaroff

Fight Bladder Cancer, Chinnor, United Kingdom

S

Shusuan Jiang

Hunan Cancer Hospital, Changsha, China

J

Ja Hyeon Ku

Seoul National University Hospital, Seoul, South Korea

S

Se Hoon Park

O

Oscar Reig Torras

Department of Medical Oncology, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Hospital Clinic, Barcelona

D

Dingwei Ye

Fudan University Shanghai Cancer Center, Shanghai

M

Marco Maruzzo

Istituto Oncologico Veneto (IOV)–IRCCS, Padua, Italy

A

Andrea Necchi

Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Milan Italy

R

Rafael Morales-Barrera

Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona

E

Emilio Francesco Giunta

Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori,” IRCCS, Meldola, Italy

J

Jae Lyun Lee

G

Giampaolo Tortora

Y

Yüksel Ürün

Ankara University Medical Faculty, Ankara, Turkey

L

Lukasz Dolowy

University Clinical Hospital, Warsaw, Poland

D

Dilek Erdem

Istinye University Medical Faculty, Istanbul, Turkey

A

Alvaro Pinto

University Hospital La Paz, Madrid

F

Fabricio Grando

Centro de Pesquisas Oncológicas, Florianópolis, Brazil

W

Wei Zou

Z

Zoe June Assaf

Genentech, South San Francisco, CA

J

Jacqueline Vuky

Genentech, South San Francisco, CA

V

Viraj Degaonkar

Azienda Ospedaliera Santa Maria, Terni, Italy

E

Elizabeth E. Steinberg

Genentech, South San Francisco, CA

J

Joaquim Bellmunt

Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

J

Jürgen E. Gschwend

Technical University Munich, Munich, Germany